# Phase 4 Coronary Artery Disease trials recruiting: 48 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 48 trials in phase 4 for Coronary Artery Disease that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 4 Coronary Artery Disease trials: 48 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-4/coronary-artery-disease

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 48
- Recruiting or not yet: 48
- Read on: November 19, 2026

## Trials

The 25 newest of 48, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 3, 2026 | NCT07912801 | Roxadustat and Myocardial Injury After Off-Pump Coronary Artery Bypass Surgery | Peking University First Hospital | Phase 4 | Not yet recruiting | Coronary Artery Disease, Coronary Artery Bypass Grafting, Hypoxia-Inducible Factor 1, Alpha Subunit, Prolyl-Hydroxylase... | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07912801) |
| September 4, 2026 | NCT07803679 | A Trial Assessing the Effectiveness of Evolocumab in Reducing the Plaque Burden in Participants With Subclinical Atheroma | Amgen | Phase 4 | Not yet recruiting | Coronary Artery Disease, Hypercholesterolemia, Atheroma, Atherosclerotic Plaque | 308 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07803679) |
| September 1, 2026 | NCT07796217 | Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy | Seoul National University Bundang Hospital | Phase 4 | Recruiting | Cardiac Event, Coronary Artery Disease, Peripheral Artery Disease, Bleeding | 2,758 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07796217) |
| August 13, 2026 | NCT07762755 | Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT | China National Center for Cardiovascular Diseases | Phase 4 | Not yet recruiting | Coronary Artery Disease, Hyperlipidaemia, Hypertriglyceridaemia, Coronary Atherosclerosis | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07762755) |
| July 31, 2026 | NCT07740330 | Oral Versus Intravenous Tranexamic Acid in Off-Pump Coronary Artery Bypass Surgery | Clinique Saint-Luc | Phase 4 | Not yet recruiting | Coronary Artery Disease, Perioperative Bleeding | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07740330) |
| July 15, 2026 | NCT07704190 | Effect of Secukinumab on Cardiorenal Outcomes in Patients With Cardiorenal Metabolic Syndrome and Atherosclerotic Cardiovascular Disease | Peking University Third Hospital | Phase 4 | Not yet recruiting | Cardiorenal Metabolic Syndrome, Atherosclerotic Cardiovascular Disease, Chronic Kidney Disease, Coronary Artery... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07704190) |
| May 29, 2026 | NCT07614230 | SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes | Sponsor not shown (see the record) | Phase 4 | Recruiting | Type 2 Diabetes Mellitus (T2DM), Coronary Artery Disease, Atherosclerosis | 144 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07614230) |
| May 29, 2026 | NCT07612774 | CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS | West China Hospital | Phase 4 | Recruiting | Coronary, Coronary Artery Disease | 232 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07612774) |
| May 18, 2026 | NCT07592507 | 1 or 6 Months of Dual Antiplatelet Therapy After Drug-coated Balloon Angioplasty for De-novo Small Coronary Artery Disease | Daejeon St. Mary's hospital | Phase 4 | Not yet recruiting | Stable Angina Pectoris, Coronary Artery Disease | 1,484 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07592507) |
| May 6, 2026 | NCT07570940 | A Study Of Stellate Ganglion Blockade With Liposomal Bupivacaine In Preventing Atrial Fibrillation After Isolated Coronary Artery Bypass... | Mayo Clinic | Phase 4 | Not yet recruiting | Coronary Artery Disease, Atrial Fibrillation | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07570940) |
| March 27, 2026 | NCT07496281 | OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation | Ewha Womans University Mokdong Hospital | Phase 4 | Not yet recruiting | Atrial Fibrillation (AF), Coronary Artery Disease, Drug-eluting Stent | 2 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07496281) |
| February 12, 2026 | NCT07405671 | Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation | Universitaire Ziekenhuizen KU Leuven | Phase 4 | Recruiting | Atrial Fibrillation (AF), Coronary Artery Disease | 988 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07405671) |
| January 20, 2026 | NCT07349875 | Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial | Nanjing First Hospital, Nanjing Medical University | Phase 4 | Recruiting | Coronary Artery Disease (CAD) | 3,826 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07349875) |
| December 18, 2025 | NCT07292909 | Effect of Empagliflozin on Inflammation | Hotel Dieu de France Hospital | Phase 4 | Recruiting | CAD - Coronary Artery Disease, Inflamation, PCI, SGLT 2 Inhibitors | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07292909) |
| November 28, 2025 | NCT07254572 | Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes | National Institute of Cardiology, Warsaw, Poland | Phase 4 | Recruiting | Coronary Artery Disease, PreDiabetes | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07254572) |
| November 10, 2025 | NCT07225842 | The Bridging Antiplatelet Therapy With Cangrelor 2 Study | University of Florida | Phase 4 | Recruiting | Coronary Arterial Disease (CAD) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07225842) |
| August 11, 2025 | NCT07116343 | Intrapleural Ropivacaine Infusion in Cardiac Surgery | Saint Petersburg State University, Russia | Phase 4 | Recruiting | Cardiac Surgery, Coronary Artery Disease, Valvular Diseases | 116 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07116343) |
| July 24, 2025 | NCT07084259 | Single Dose PCSK9 Inhibitor to Improve Cardiovascular Outcomes After PCI: A Pilot Study | Hanyang University Seoul Hospital | Phase 4 | Not yet recruiting | Coronary Artery Disease | 352 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07084259) |
| June 17, 2025 | NCT07025148 | Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk... | University of Florida | Phase 4 | Recruiting | Coronary Arterial Disease (CAD), Percutaneous Coronary Intervention (PCI) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07025148) |
| April 27, 2025 | NCT06946589 | Cardiac Changes After Effective Dose Carbetocin for Elective Caesarian Section | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Cardiac Ischemia, Cesarian Section | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06946589) |
| April 17, 2025 | NCT06932874 | Metformin Hydrochloride Sustained-release Tablets (Ⅲ) in Patients With Type 2 Diabetes Mellitus Complicated With Coronary Heart Disease | China National Center for Cardiovascular Diseases | Phase 4 | Recruiting | Atherosclerotic Heart Disease, Type 2 Diabetes | 356 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06932874) |
| April 8, 2025 | NCT06917664 | Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease | China National Center for Cardiovascular Diseases | Phase 4 | Recruiting | Coronary Artery Disease, Ischemic Mitral Regurgitation, Angiotensin Receptor/Neprilysin Inhibitor | 220 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06917664) |
| April 3, 2025 | NCT06909565 | Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary... | Duke University | Phase 4 | Recruiting | Percutaneous Coronary Intervention, Peripheral Endovascular Intervention | 6,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06909565) |
| March 7, 2025 | NCT06864234 | Effect of Beta-blockers on Coronary Flow and Resistance in Patients With ANOCA | VZW Cardiovascular Research Center Aalst | Phase 4 | Recruiting | Coronary Arterial Disease (CAD), Angina (Stable), Microvascular Circulation | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06864234) |
| February 11, 2025 | NCT06821191 | Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching... | University of Florida | Phase 4 | Recruiting | Coronary Artery Disease | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06821191) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University of Florida | 5 |
| China National Center for Cardiovascular Diseases | 4 |
| VA Office of Research and Development | 2 |
| Nanjing First Hospital, Nanjing Medical University | 2 |
| Fundación EPIC | 1 |
| Samsung Medical Center | 1 |
| Region Skane | 1 |
| Universitaire Ziekenhuizen KU Leuven | 1 |
| Clinique Saint-Luc | 1 |
| Federico II University | 1 |
| National Institute of Cardiology, Warsaw, Poland | 1 |
| Peking University Third Hospital | 1 |
| Seoul National University Hospital | 1 |
| Seoul National University Bundang Hospital | 1 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 1 |
| Asan Medical Center | 1 |
| CoreAalst BV | 1 |
| Shanghai Zhongshan Hospital | 1 |
| Saint Vincent's Hospital, Korea | 1 |
| Hotel Dieu de France Hospital | 1 |
| Saint Petersburg State University, Russia | 1 |
| Duke University | 1 |
| St. Antonius Hospital | 1 |
| Peking University First Hospital | 1 |
| VZW Cardiovascular Research Center Aalst | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 13 |
| United States | 9 |
| South Korea | 8 |
| Belgium | 5 |
| Spain | 2 |
| Italy | 2 |
| Poland | 2 |
| Netherlands | 2 |
| Sweden | 1 |
| Denmark | 1 |
| Canada | 1 |
| France | 1 |
| Germany | 1 |
| Lebanon | 1 |
| Japan | 1 |
| Russia | 1 |
| Iran | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Structural engineering firms in the United States](https://specstream.ai/data/businesses/structural-engineering-firms/united-states)
- [IT companies in the United States](https://specstream.ai/data/businesses/it-companies/united-states)
- [Cardiothoracic surgery practices in the United States](https://specstream.ai/data/businesses/cardiothoracic-surgery-practices/united-states)
- [Smoothie and juice bars in the United States](https://specstream.ai/data/businesses/smoothie-and-juice-bars/united-states)
- [Importers in the United States](https://specstream.ai/data/businesses/importers/united-states)
- [Brewing supply stores in the United States](https://specstream.ai/data/businesses/brewing-supply-stores/united-states)
